Account
Inquiry
XCE Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This innovative peptide demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists.
The molecular structure of XCE Tirzepatide features a PEG-modified lysine side chain that enhances water solubility while maintaining biological activity. As a dual agonist, it exhibits greater affinity for GIP receptors while effectively activating GLP-1 receptors, producing synergistic metabolic effects.
Clinical research indicates XCE Tirzepatide promotes significant weight reduction in overweight subjects, with studies showing dose-dependent efficacy. The compound has received FDA Fast Track designation for obesity-related research applications.
Our XCE Tirzepatide is produced under strict pharmaceutical-grade conditions, ensuring high purity and consistent quality for research purposes. The white powder form provides excellent stability and convenient handling for laboratory use.
For optimal preservation, store XCE Tirzepatide in a cool, dry environment protected from light. Avoid repeated freeze-thaw cycles and minimize exposure to air when handling. Aliquot according to experimental requirements to maintain stability.
